HUMAN`s specials
Researchers uncover how APOE4 damages brain vessels
(Tehran Ana)- Researchers at Mount Sinai have identified how the APOE4 genetic variant, the strongest genetic risk factor for Alzheimer’s disease, damages brain blood vessels and promotes the buildup of harmful proteins.
Russian scientists discover a way to restore fibrotic liver tissue
(Tehran Ana)- Russian scientists have found that mesenchymal stromal cells may help restore liver tissue affected by fibrosis in laboratory mice.
Smart wire maps stroke clots in real time
(Tehran Ana)- A sensor-equipped smart wire has shown promise in identifying the composition, location and size of stroke-causing blood clots in real time during clot-removal procedures.
How stress and anxiety can affect the digestive system
(Tehran Ana)- Stress-related hormonal changes may affect the gastrointestinal system and contribute to the development or worsening of some chronic digestive disorders.
Muscle loss may be an important warning sign of dementia
(Tehran Ana)- A new study suggests that age-related loss of muscle mass and strength may be associated with a higher risk of dementia.
Reddit sheds light on drug side effects
(Tehran Ana)- Researchers at the University of Pennsylvania found that discussions on Reddit can influence how users interpret and report side effects of GLP-1 medications.
A promising weapon against cancer recurrence
(Tehran Ana)- A scientific review suggests that aerobic exercise after cancer treatment may reduce the risk of recurrence and death.
Single stem cell injection cuts osteoporosis-related fractures by 94%
(Tehran Ana)- A study published in Cell has tested an experimental stem cell therapy for advanced osteoporosis, reporting a 94% reduction in fracture rates over two years following a single injection.
One-time cell injection offers new hope for osteoporosis treatment
(Tehran Ana)- A small clinical trial suggests that a single injection of genetically modified bone marrow cells may help rebuild fragile bones and reduce fractures in older women with advanced osteoporosis.
Technology-to-Market
